Investor Overview

Welcome to the MDS Investor Relations section. Here you will find the latest information on the value of MDS — from financial data and shareholder services, to reports and events.

Corporate Profile:

MDS (TSX: MDS; NYSE: MDZ), a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. MDS Inc. is a leading global provider of innovative technologies for use in medical imaging and radiotherapeutics, sterilization, and pharmaceutical contract research.

MDS Nordion is a leading global provider of innovative technologies for medical imaging and radiotherapeutics, and sterilization. It operates in an estimated US$4 billion market. Learn more.

MDS Pharma Services is a leading global provider of Early Stage pharmaceutical research services for pharmaceutical and biotechnology companies. MDS Pharma Services currently operates in an estimated US$5 billion market. Learn more.  

MDS was founded in 1969 and currently has more the 2,400 highly skilled people operating in nine countries.

MDS trades on the Toronto Stock Exchange (TSX: MDS) and on the New York Stock Exchange (NYSE: MDZ).